Which has higher valuation & earnings, HAE or STAA?

Haemonetics has higher revenue and earnings than STAAR Surgical. Haemonetics is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Haemonetics $1.33B 3.69 $97.31M $2.04 53.09 STAAR Surgical $239.44M 5.00 -$80.45M $0.07 341.43

Does the media favor HAE or STAA?

In the previous week, Haemonetics had 1 more articles in the media than STAAR Surgical. MarketBeat recorded 16 mentions for Haemonetics and 15 mentions for STAAR Surgical. Haemonetics' average media sentiment score of 0.93 beat STAAR Surgical's score of 0.12 indicating that Haemonetics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Haemonetics 10 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive STAAR Surgical 3 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings & valuation, STAA or LIVN?

STAAR Surgical has higher earnings, but lower revenue than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio STAAR Surgical $239.44M 5.00 -$80.45M $0.07 341.43 LivaNova $1.39B 3.16 -$242.47M $3.38 23.59

Does the media refer more to STAA or LIVN?

In the previous week, STAAR Surgical had 12 more articles in the media than LivaNova. MarketBeat recorded 15 mentions for STAAR Surgical and 3 mentions for LivaNova. LivaNova's average media sentiment score of 1.01 beat STAAR Surgical's score of 0.12 indicating that LivaNova is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 3 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral LivaNova 2 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings and valuation, ITGR or STAA?

Integer has higher revenue and earnings than STAAR Surgical. Integer is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Integer $1.84B 2.31 $102.81M $3.66 34.26 STAAR Surgical $239.44M 5.00 -$80.45M $0.07 341.43

Does the media prefer ITGR or STAA?

In the previous week, STAAR Surgical had 11 more articles in the media than Integer. MarketBeat recorded 15 mentions for STAAR Surgical and 4 mentions for Integer. Integer's average media sentiment score of 1.17 beat STAAR Surgical's score of 0.12 indicating that Integer is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Integer 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive STAAR Surgical 3 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to STAA or IRTC?

In the previous week, STAAR Surgical had 7 more articles in the media than iRhythm Technologies. MarketBeat recorded 15 mentions for STAAR Surgical and 8 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.39 beat STAAR Surgical's score of 0.12 indicating that iRhythm Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STAAR Surgical 3 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral iRhythm Technologies 2 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor PLSE or STAA?

In the previous week, STAAR Surgical had 5 more articles in the media than Pulse Biosciences. MarketBeat recorded 15 mentions for STAAR Surgical and 10 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 0.71 beat STAAR Surgical's score of 0.12 indicating that Pulse Biosciences is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pulse Biosciences 3 Very Positive mention(s) 4 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive STAAR Surgical 3 Very Positive mention(s) 4 Positive mention(s) 4 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral

STAAR Surgical (STAA) Competitors

$23.94 -0.72 (-2.92%)

As of 11:51 AM Eastern

Compare

STAA vs. HAE, LIVN, ITGR, IRTC, and PLSE

Should you buy STAAR Surgical stock or one of its competitors? STAAR Surgical's main competitors and comparable companies include Haemonetics (HAE), LivaNova (LIVN), Integer (ITGR), iRhythm Technologies (IRTC), and Pulse Biosciences (PLSE). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does STAAR Surgical compare to Haemonetics?

Haemonetics (NYSE:HAE) and STAAR Surgical (NASDAQ:STAA) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their profitability, analyst recommendations, media sentiment, earnings, institutional ownership, dividends, valuation and risk.

Haemonetics presently has a consensus target price of $95.00, indicating a potential downside of 12.29%. STAAR Surgical has a consensus target price of $28.40, indicating a potential upside of 18.83%. Given STAAR Surgical's higher probable upside, analysts plainly believe STAAR Surgical is more favorable than Haemonetics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Haemonetics	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73
STAAR Surgical	3 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.08

Haemonetics has a beta of 0.52, suggesting that its share price is 48% less volatile than the broader market. Comparatively, STAAR Surgical has a beta of 1.26, suggesting that its share price is 26% more volatile than the broader market.

99.7% of Haemonetics shares are owned by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are owned by institutional investors. 2.1% of Haemonetics shares are owned by company insiders. Comparatively, 39.9% of STAAR Surgical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Haemonetics has higher revenue and earnings than STAAR Surgical. Haemonetics is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Haemonetics	$1.33B	3.69	$97.31M	$2.04	53.09
STAAR Surgical	$239.44M	5.00	-$80.45M	$0.07	341.43

Haemonetics has a net margin of 7.12% compared to STAAR Surgical's net margin of 1.13%. Haemonetics' return on equity of 27.55% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Haemonetics	7.12%	27.55%	9.65%
STAAR Surgical	1.13%	9.05%	6.99%

In the previous week, Haemonetics had 1 more articles in the media than STAAR Surgical. MarketBeat recorded 16 mentions for Haemonetics and 15 mentions for STAAR Surgical. Haemonetics' average media sentiment score of 0.93 beat STAAR Surgical's score of 0.12 indicating that Haemonetics is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Haemonetics	10 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
STAAR Surgical	3 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

Haemonetics beats STAAR Surgical on 11 of the 16 factors compared between the two stocks.

How does STAAR Surgical compare to LivaNova?

STAAR Surgical (NASDAQ:STAA) and LivaNova (NASDAQ:LIVN) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their institutional ownership, profitability, earnings, dividends, media sentiment, valuation, risk and analyst recommendations.

STAAR Surgical presently has a consensus target price of $28.40, indicating a potential upside of 18.83%. LivaNova has a consensus target price of $83.50, indicating a potential upside of 4.72%. Given STAAR Surgical's higher possible upside, equities analysts plainly believe STAAR Surgical is more favorable than LivaNova.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	3 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.08
LivaNova	0 Sell rating(s)	4 Hold rating(s)	6 Buy rating(s)	1 Strong Buy rating(s)	2.73

96.7% of STAAR Surgical shares are owned by institutional investors. Comparatively, 97.6% of LivaNova shares are owned by institutional investors. 39.9% of STAAR Surgical shares are owned by company insiders. Comparatively, 0.4% of LivaNova shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, STAAR Surgical had 12 more articles in the media than LivaNova. MarketBeat recorded 15 mentions for STAAR Surgical and 3 mentions for LivaNova. LivaNova's average media sentiment score of 1.01 beat STAAR Surgical's score of 0.12 indicating that LivaNova is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	3 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
LivaNova	2 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

LivaNova has a net margin of 12.82% compared to STAAR Surgical's net margin of 1.13%. LivaNova's return on equity of 16.35% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	1.13%	9.05%	6.99%
LivaNova	12.82%	16.35%	7.76%

STAAR Surgical has higher earnings, but lower revenue than LivaNova. LivaNova is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$239.44M	5.00	-$80.45M	$0.07	341.43
LivaNova	$1.39B	3.16	-$242.47M	$3.38	23.59

STAAR Surgical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market. Comparatively, LivaNova has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market.

Summary

LivaNova beats STAAR Surgical on 9 of the 16 factors compared between the two stocks.

How does STAAR Surgical compare to Integer?

Integer (NYSE:ITGR) and STAAR Surgical (NASDAQ:STAA) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, analyst recommendations, profitability, institutional ownership, valuation, risk, dividends and media sentiment.

Integer has a net margin of 6.97% compared to STAAR Surgical's net margin of 1.13%. Integer's return on equity of 12.79% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Integer	6.97%	12.79%	6.48%
STAAR Surgical	1.13%	9.05%	6.99%

Integer has higher revenue and earnings than STAAR Surgical. Integer is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Integer	$1.84B	2.31	$102.81M	$3.66	34.26
STAAR Surgical	$239.44M	5.00	-$80.45M	$0.07	341.43

Integer has a beta of 0.61, suggesting that its stock price is 39% less volatile than the broader market. Comparatively, STAAR Surgical has a beta of 1.26, suggesting that its stock price is 26% more volatile than the broader market.

99.3% of Integer shares are owned by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are owned by institutional investors. 1.1% of Integer shares are owned by company insiders. Comparatively, 39.9% of STAAR Surgical shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Integer currently has a consensus target price of $109.86, suggesting a potential downside of 12.38%. STAAR Surgical has a consensus target price of $28.40, suggesting a potential upside of 18.83%. Given STAAR Surgical's stronger consensus rating and higher probable upside, analysts clearly believe STAAR Surgical is more favorable than Integer.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Integer	0 Sell rating(s)	13 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.07
STAAR Surgical	3 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.08

In the previous week, STAAR Surgical had 11 more articles in the media than Integer. MarketBeat recorded 15 mentions for STAAR Surgical and 4 mentions for Integer. Integer's average media sentiment score of 1.17 beat STAAR Surgical's score of 0.12 indicating that Integer is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Integer	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
STAAR Surgical	3 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

STAAR Surgical beats Integer on 10 of the 17 factors compared between the two stocks.

How does STAAR Surgical compare to iRhythm Technologies?

STAAR Surgical (NASDAQ:STAA) and iRhythm Technologies (NASDAQ:IRTC) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, risk and dividends.

iRhythm Technologies has higher revenue and earnings than STAAR Surgical. iRhythm Technologies is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
STAAR Surgical	$239.44M	5.00	-$80.45M	$0.07	341.43
iRhythm Technologies	$747.14M	5.60	-$44.55M	-$0.43	N/A

STAAR Surgical presently has a consensus target price of $28.40, suggesting a potential upside of 18.83%. iRhythm Technologies has a consensus target price of $179.93, suggesting a potential upside of 41.66%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, analysts plainly believe iRhythm Technologies is more favorable than STAAR Surgical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
STAAR Surgical	3 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.08
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94

STAAR Surgical has a beta of 1.26, indicating that its stock price is 26% more volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.3, indicating that its stock price is 30% more volatile than the broader market.

In the previous week, STAAR Surgical had 7 more articles in the media than iRhythm Technologies. MarketBeat recorded 15 mentions for STAAR Surgical and 8 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 0.39 beat STAAR Surgical's score of 0.12 indicating that iRhythm Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
STAAR Surgical	3 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
iRhythm Technologies	2 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

96.7% of STAAR Surgical shares are owned by institutional investors. 39.9% of STAAR Surgical shares are owned by company insiders. Comparatively, 1.0% of iRhythm Technologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

STAAR Surgical has a net margin of 1.13% compared to iRhythm Technologies' net margin of -1.69%. iRhythm Technologies' return on equity of 10.11% beat STAAR Surgical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
STAAR Surgical	1.13%	9.05%	6.99%
iRhythm Technologies	-1.69%	10.11%	1.53%

Summary

iRhythm Technologies beats STAAR Surgical on 10 of the 17 factors compared between the two stocks.

How does STAAR Surgical compare to Pulse Biosciences?

Pulse Biosciences (NASDAQ:PLSE) and STAAR Surgical (NASDAQ:STAA) are both healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their media sentiment, dividends, analyst recommendations, valuation, profitability, institutional ownership, risk and earnings.

Pulse Biosciences has higher earnings, but lower revenue than STAAR Surgical. Pulse Biosciences is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pulse Biosciences	$1.19M	2,812.79	-$72.78M	-$1.18	N/A
STAAR Surgical	$239.44M	5.00	-$80.45M	$0.07	341.43

Pulse Biosciences presently has a consensus price target of $45.25, suggesting a potential downside of 6.04%. STAAR Surgical has a consensus price target of $28.40, suggesting a potential upside of 18.83%. Given STAAR Surgical's higher possible upside, analysts clearly believe STAAR Surgical is more favorable than Pulse Biosciences.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pulse Biosciences	1 Sell rating(s)	0 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.60
STAAR Surgical	3 Sell rating(s)	7 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.08

In the previous week, STAAR Surgical had 5 more articles in the media than Pulse Biosciences. MarketBeat recorded 15 mentions for STAAR Surgical and 10 mentions for Pulse Biosciences. Pulse Biosciences' average media sentiment score of 0.71 beat STAAR Surgical's score of 0.12 indicating that Pulse Biosciences is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pulse Biosciences	3 Very Positive mention(s)	4 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
STAAR Surgical	3 Very Positive mention(s)	4 Positive mention(s)	4 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral

Pulse Biosciences has a beta of 1.61, indicating that its share price is 61% more volatile than the broader market. Comparatively, STAAR Surgical has a beta of 1.26, indicating that its share price is 26% more volatile than the broader market.

76.9% of Pulse Biosciences shares are held by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are held by institutional investors. 74.0% of Pulse Biosciences shares are held by company insiders. Comparatively, 39.9% of STAAR Surgical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

STAAR Surgical has a net margin of 1.13% compared to Pulse Biosciences' net margin of -6,755.78%. STAAR Surgical's return on equity of 9.05% beat Pulse Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pulse Biosciences	-6,755.78%	-94.42%	-79.96%
STAAR Surgical	1.13%	9.05%	6.99%

Summary

STAAR Surgical beats Pulse Biosciences on 10 of the 17 factors compared between the two stocks.

Get STAAR Surgical News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding STAA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

STAA vs. The Competition

Export

Metric	STAAR Surgical	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$1.20B	$5.80B	$7.26B	$12.78B
Dividend Yield	N/A	1.76%	2.55%	10.29%
P/E Ratio	341.48	25.98	269.16	24.14
Price / Sales	5.00	40.97	615.85	97.71
Price / Cash	N/A	33.29	78.23	52.73
Price / Book	3.28	5.97	13.06	6.20
Net Income	-$80.45M	$148.28M	$3.46B	$347.71M
7 Day Performance	-5.65%	0.48%	1.37%	-0.63%
1 Month Performance	-0.29%	5.66%	4.49%	2.13%
1 Year Performance	-14.55%	9.58%	27.84%	20.34%

STAAR Surgical Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
STAA STAAR Surgical	3.2078 of 5 stars	$23.94 -2.9%	$28.40 +18.6%	-11.8%	$1.20B	$239.44M	342.05	1,211	Analyst Forecast
HAE Haemonetics	2.0982 of 5 stars	$104.58 +15.9%	$92.44 -11.6%	+99.5%	$4.74B	$1.33B	51.09	3,009	Analyst Forecast
LIVN LivaNova	2.5362 of 5 stars	$79.43 -2.5%	$83.50 +5.1%	+51.2%	$4.38B	$1.47B	23.51	3,300	Positive News Analyst Upgrade
ITGR Integer	2.5894 of 5 stars	$125.15 +0.1%	$109.86 -12.2%	+17.8%	$4.25B	$1.85B	34.19	11,000	Positive News
IRTC iRhythm Technologies	3.9755 of 5 stars	$117.07 +0.1%	$179.93 +53.7%	-21.3%	$3.85B	$825.34M	N/A	2,400	Analyst Forecast

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:STAA) was last updated on 8/20/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

STAAR Surgical (STAA) Competitors

STAA vs. HAE, LIVN, ITGR, IRTC, and PLSE

How does STAAR Surgical compare to Haemonetics?

Summary

How does STAAR Surgical compare to LivaNova?

Summary

How does STAAR Surgical compare to Integer?

Summary

How does STAAR Surgical compare to iRhythm Technologies?

Summary

How does STAAR Surgical compare to Pulse Biosciences?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STAA vs. The Competition

STAAR Surgical Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

STAAR Surgical (STAA) Competitors

STAA vs. HAE, LIVN, ITGR, IRTC, and PLSE

How does STAAR Surgical compare to Haemonetics?

Do analysts recommend HAE or STAA?

Which has more risk & volatility, HAE or STAA?

Do insiders and institutionals have more ownership in HAE or STAA?

Which has higher valuation & earnings, HAE or STAA?

Is HAE or STAA more profitable?

Does the media favor HAE or STAA?

Summary

How does STAAR Surgical compare to LivaNova?

Do analysts prefer STAA or LIVN?

Do institutionals and insiders believe in STAA or LIVN?

Does the media refer more to STAA or LIVN?

Is STAA or LIVN more profitable?

Which has higher earnings & valuation, STAA or LIVN?

Which has more volatility & risk, STAA or LIVN?

Summary

How does STAAR Surgical compare to Integer?

Is ITGR or STAA more profitable?

Which has higher earnings and valuation, ITGR or STAA?

Which has more risk and volatility, ITGR or STAA?

Do institutionals & insiders hold more shares of ITGR or STAA?

Do analysts rate ITGR or STAA?

Does the media prefer ITGR or STAA?

Summary

How does STAAR Surgical compare to iRhythm Technologies?

Which has higher earnings & valuation, STAA or IRTC?

Do analysts rate STAA or IRTC?

Which has more volatility & risk, STAA or IRTC?

Does the media refer more to STAA or IRTC?

Do insiders and institutionals have more ownership in STAA or IRTC?

Is STAA or IRTC more profitable?

Summary

How does STAAR Surgical compare to Pulse Biosciences?

Which has preferable earnings and valuation, PLSE or STAA?

Do analysts prefer PLSE or STAA?

Does the media favor PLSE or STAA?

Which has more volatility and risk, PLSE or STAA?

Do institutionals & insiders hold more shares of PLSE or STAA?

Is PLSE or STAA more profitable?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

STAA vs. The Competition

STAAR Surgical Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools